13D from Dan Loeb Filed on LGND Urging to Sell Company; Says Worth $14/Sh
Tweet Send to a Friend
Daniel S. Loeb/Third Point issues 13D filing on Ligand Pharmaceuticals (OTC: LGND) disclosing 9.47% stake in the company. The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
